not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
7
positions filed
in the 665 files tracked
7
legislative files
of 665 tracked
4
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Work at Regulatory Institute? so we know who speaks for it.
Their record over time
Regulatory Institute filed 7 positions between 7 Sept 2022 and 9 Mar 2026, across 7 of the 665 legislative files tracked here, attaching a full position paper 4 times.
Regulatory Institute Submission on the Proposal for a Regulation on the Digital Omnibus on AI COM(2025) 836 final www.howtoregulate.org The Regulatory Institute is pleased to share its submission on the Proposal for a Regulation amending Regulations (EU) 2024/1689 and (EU) 2018/1139 as regards the simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI), COM(2025)…
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
The Regulatory Institute is pleased to share its EU Legislators' Toolbox. The toolbox contains over 340 tools designed and actually used to strengthen EU regulatory systems and standardise their implementation. It draws on knowledge from many different regulatory sectors. Reference wordings can be found in the references cited in the toolbox and the attached document.
We are pleased to submit our response to the Call for Evidence on the targeted revision of the EU rules for medical devices and in vitro diagnostics. In terms of potential simplification and burden reduction for economic operators, we recommend continuing the approach taken for decades by EU medical devices legislation: integrating substantial requirements from other EU legislation to avoid double certification.
The Regulatory Institute is pleased to respond to the “Blood, tissues and cells for medical treatments & therapies – revised EU rules” proposal. The Regulatory Institute is a non-profit think tank which identifies, develops and promotes best regulatory practices. We aim to improve regulation globally so that regulations benefit us all.
Regulatory Institute Response to the Call for Evidence on Biocidal Products Regulation – Evaluation www.howtoregulate.org The Regulatory Institute is pleased to submit its response to the Call for Evidence on the Biocidal Products Regulation – Evaluation. The Regulatory Institute is a non-profit think tank committed to improving regulation globally so that regulations benefit us all.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
The Regulatory Institute is pleased to submit its feedback on the EU strategy on combating trafficking in human beings 2026-2030. The Regulatory Institute is a non-profit think tank dedicated to improving regulation globally so that regulations benefit us all.
To Whom It May Concern, The Regulatory Institute (https://www.howtoregulate.org) is pleased to provide its feedback to the Proposal for a Directive on liability for defective products COM(2022)495. The Regulatory Institute is a non-profit think tank which identifies, develops and promotes best regulatory practices. We aim to improve regulation globally so that regulations benefit us all.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Regulatory Institute next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Everything on this page comes from Regulatory Institute’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.
